Table 5.
β ± SE | p-Value | q-Value | |
---|---|---|---|
C-glycosyltryptophan | 0.4 ± 0.1 | 4.4E − 09 | 2.5E − 07 |
Erythritol | 0.3 ± 0.1 | 6.3E − 08 | 2.7E − 06 |
Pseudouridine | 0.4 ± 0.1 | 1.2E − 07 | 4.2E − 06 |
1-Methylurate | 0.2 ± 0.0 | 8.0E − 07 | 2.1E − 05 |
4-Acetamidobutanoate | 0.3 ± 0.1 | 9.2E − 07 | 2.2E − 05 |
N1-methyladenosine | 0.4 ± 0.1 | 2.5E − 06 | 4.7E − 05 |
N-acetylalanine | 0.4 ± 0.1 | 3.2E − 06 | 5.6E − 05 |
N-formylmethionine | 0.3 ± 0.1 | 4.8E − 06 | 7.3E − 05 |
Arabonate | 0.1 ± 0.0 | 1.3E − 05 | 0.0002 |
Urea | 0.2 ± 0.0 | 2.1E − 05 | 0.0002 |
Phenylacetylglutamine | 0.1 ± 0.0 | 2.9E − 05 | 0.0003 |
Erythronate | 0.2 ± 0.0 | 5.9E − 05 | 0.0006 |
Myo-inositol | 0.2 ± 0.0 | 0.0001 | 0.0009 |
Glutaroyl carnitine | 0.1 ± 0.0 | 0.0002 | 0.002 |
2-Hydroxyisobutyrate | 0.2 ± 0.0 | 0.0004 | 0.003 |
Threitol | 0.1 ± 0.0 | 0.0004 | 0.003 |
Glucuronate | 0.1 ± 0.0 | 0.0005 | 0.003 |
N6-acetyllysine | −0..2 ± 0.1 | 0.001 | 0.007 |
N-acetylserine | 0.2 ± 0.0 | 0.001 | 0.008 |
Dimethylglycine | 0.2 ± 0.0 | 0.002 | 0.009 |
Isobutrylcarnitine | 0.1 ± 0.0 | 0.003 | 0.01 |
N-acetylthreonine | 0.2 ± 0.1 | 0.003 | 0.01 |
Methylglutarylcarnitine | 0.1 ± 0.0 | 0.003 | 0.01 |
Arabitol | 0.2 ± 0.1 | 0.003 | 0.01 |
Serine | − 0.2 ± 0.1 | 0.003 | 0.02 |
N1-methyl-2-pyridone-5-carboxamide | 0.1 ± 0.0 | 0.005 | 0.02 |
Tiglyl carnitine | 0.1 ± 0.0 | 0.006 | 0.03 |
Cis-4-decenoyl carnitine | 0.1 ± 0.0 | 0.007 | 0.03 |
Ergothioneine | − 0.1 ± 0.0 | 0.007 | 0.03 |
2-Methylbutyroylcarnitine | 0.1 ± 0.1 | 0.009 | 0.04 |
Cortisone | − 0.2 ± 0.1 | 0.01 | 0.05 |
Butyrylcarnitine | 0.1 ± 0.0 | 0.02 | 0.06 |
Hexanoylcarnitine | 0.1 ± 0.0 | 0.03 | 0.07 |
Indolelactate | 0.1 ± 0.0 | 0.04 | 0.10 |
Glutamine | − 0.2 ± 0.1 | 0.05 | 0.12 |
Metabolites significantly associated with NDM/LDM and with a circulating marker of immune activation (kynurenine/tryptophan) are shown with parameter estimates and standard errors (β ± SE), and with p- and q-values.